These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1576669)

  • 1. Anticoagulant action of vanadate.
    Funakoshi T; Shimada H; Kojima S; Shoji S; Kubota Y; Morita T; Tominaga N; Ueki H
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):174-6. PubMed ID: 1576669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant action of rare earth metals.
    Funakoshi T; Furushima K; Shimada H; Kojima S
    Biochem Int; 1992 Oct; 28(1):113-9. PubMed ID: 1445385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulatory release of lipoprotein lipase activity from rat fat pads by vanadate.
    Ueki H; Sera M; Tanaka K
    Arch Biochem Biophys; 1989 Jul; 272(1):18-24. PubMed ID: 2735761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM; Heeb MJ; Griffin JH
    Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of increasing effect of vanadate on glycogen content and lipoprotein lipase activity in fat pads by 5-N,N-hexamethylene amiloride.
    Ueki H; Sera M; Tominaga N; Morita T; Sugino E; Hibino S
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):542-3. PubMed ID: 1606655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of vanadate on 3',5'-cyclic guanosine monophosphate-inhibited low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads.
    Ueki H; Okuhama R; Sera M; Inoue T; Tominaga N; Morita T
    Endocrinology; 1992 Jul; 131(1):441-6. PubMed ID: 1319324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
    Callas DD; Hoppensteadt D; Fareed J
    Semin Thromb Hemost; 1995; 21(2):177-83. PubMed ID: 7660140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadate-stimulated release of hepatic lipase activity from liver.
    Morita T; Mikami F; Kanagawa A; Sera M; Ueki H
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3287-9. PubMed ID: 1814620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration.
    Jameson GW; Roberts DV; Adams RW; Kyle WS; Elmore DT
    Biochem J; 1973 Jan; 131(1):107-17. PubMed ID: 4737291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant activity of enzymatically synthesized amylose derivatives containing carboxy or sulfonate groups.
    Takahara J; Hosoya K; Sunako M; Hirohara S; Terada K; Ando T; Tanihara M
    Acta Biomater; 2010 Aug; 6(8):3138-45. PubMed ID: 20206721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.
    Lockett JM; Mast AE
    Biochemistry; 2002 Apr; 41(15):4989-97. PubMed ID: 11939795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes.
    Jackson TK; Salhanick AI; Sparks JD; Sparks CE; Bolognino M; Amatruda JM
    Diabetes; 1988 Sep; 37(9):1234-40. PubMed ID: 3044889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Apr; 68(4):645-9. PubMed ID: 7378640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthovanadate stimulates cyclic guanosine monophosphate-inhibited cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads through activation of particulate myelin basic protein kinase by protein tyrosine kinase.
    Ueki H; Mitsugi S; Kawashima Y; Motoyashiki T; Morita T
    Endocrinology; 1997 Jul; 138(7):2784-9. PubMed ID: 9202218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure.
    Smith CM; Hanahan DJ
    Biochemistry; 1976 May; 15(9):1830-8. PubMed ID: 1268197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.